Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (4): 621-627. doi: 10.19723/j.issn.1671-167X.2022.04.007

Previous Articles     Next Articles

Correlation between daily fluid intake behavioral habits and pathological characteristics of upper tract urothelial carcinoma

Zhi-hua LI1,2,Chun-ru XU1,Yin LIU1,2,Hua GUAN1,2,Meng ZHANG1,2,Xin-yan CHE1,2,Qi TANG1,Yan-bo HUANG1,2,*(),Xue-song LI1,*(),Li-qun HOU1   

  1. 1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Centre, Beijing 100034, China
    2. Department of Nursing, Peking University First Hospital, Beijing 100034, China
  • Received:2022-04-06 Online:2022-08-18 Published:2022-08-11
  • Contact: Yan-bo HUANG,Xue-song LI E-mail:hyb1273@126.com;pineneedle@sina.com

Abstract:

Objective: To investigate the correlation between drinking habits and pathological characteristics of patients with upper tract urothelial carcinoma (UTUC). Methods: A preoperative questionnaire survey was conducted to understand the drinking habits of UTUC patients who were admitted to the Department of Urology, Peking University First Hospital for radical nephroureterectomy within one year from August 2020 to July 2021, and statistical analysis was performed in combination with their postoperative pathological characteristics. The statistical procedure was performed using SPSS 22.0 software, and firstly, the preliminary analysis was performed one by one using the columnar χ2 test on the pathological characteristics of UTUC tumors as the dependent variable and the factors related to patients' general information, past history and drinking habits as the independent variables, and the independent variables that met P < 0.2 between the case and control groups for each dependent variable were specified for screening. The screened variables were included in the binary Logistic regression analysis. A difference of P < 0.05 was used to indicate a statistically significant difference. Results: A total of 239 patients, 134 males and 105 females, with a mean age of (68.1±9.98)years and a median disease duration of 4.8 months, were included in this study. Multifactorial Logistic regression results suggested that after adjusting for the effects of other variables, UTUC patients who had the habit of drinking at least once every hour during the daytime had a significantly increased risk of high grade (G3) tumors(OR=1.941, 95%CI: 0.352-1.029, P < 0.01); these patients also had a significantly decreased risk of multifocal UTUC tumors (OR=0.344, 95% CI: 1.18-5.582, P=0.004). The patients who had the habit of drinking over 100 mL water each time had a significantly decreased risk of mutifocal UTUC incidence (OR=0.477, 95%CI: 0.225-1.012, P=0.046). Patients who pay attention to daily water intakes had a significantly increased risk of renipelvic carcinoma (OR=2.530, 95%CI: 1.434-4.463, P=0.001) and a significantly decreased risk of ureteral carcinoma (OR=0.314, 95%CI: 0.172-0.573, P < 0.01). Other variables included in the regression model did not differ significantly in their effects on the occurrence of tumor pathological characteristics. Conclusion: Having the awareness of drinking water every 1 h during the day, drinking over 100 mL water each time, having the awareness of daily drinking habits correlated significantly with pathological characteristics of UTUC such as the presence of G3 tumor, multifocal tumors and location of the tumor. This conclusion still needs to be verified by subsequent trials with higher levels of evidence.

Key words: Upper tract urothelial carcinoma, Drinking habit, Pathological characteristic, Correlation analysis

CLC Number: 

  • R737.1

Table 1

Drinking habits of 239 patients diagnosed with upper tract urothelial carcinoma"

Items n %
Type of water
  Boiled water 140 58.58
  Mineral water 18 7.53
  Purified water 37 15.48
  Tea or other beverage 44 18.41
Timing of drinking water
  When feel thirsty 106 44.35
  Drinking water intentionally 133 55.65
Daily water intakes
  500-1 000 mL 32 13.39
  >1 000-1 500 mL 58 24.27
  >1 500-2 000 mL 56 23.43
  >2 000 mL 93 38.91
Drink at least once every hour during the daytime 89 37.24
Drink over 100 mL water every time 190 79.50
Drink over 200 mL water before bed 104 43.51
Drink over 200 mL water at night 39 16.32
Drink over 200 mL water when get up 184 76.99
Drink over 200 mL tea every day 96 40.17
Drink over 200 mL carbonated drinks every day 3 1.26
Drink over 200 mL coffee every day 8 3.25
Drink over 200 mL juice every day 3 1.26
Drink over 200 mL milk every day 112 46.86
Paying attention to daily water intakes 140 58.58
Having the will to drink more water every day intentionally 135 56.49
Lower urinary track obstruction disease history/ BPH history 55 23.01
Having the habit to hold back urine 35 14.64

Table 2

Factors included in the Logistic regression model after Chi-square test"

Case group Control group χ2 P
G3 tumor,n 138 101
  Drink at least once every hour, n(%) 44 (31.88) 45 (44.55) 4.006 0.045*
  Drink over 200 mL water when get up, n(%) 102 (73.91) 82 (81.19) 1.742 0.187
  Smoking history, n(%) 36 (26.07) 38 (37.62) 3.631 0.057
  Family history of cancer, n(%) 48 (34.78) 25 (24.75) 2.766 0.096
Multifocal tumor,n 39 200
  Time of drinking
    When thirsty, n(%) 13 (33.33) 93 (46.50) 2.292 0.130
    Drinking water intentionally, n(%) 26 (66.67) 107 (53.50)
  Drink at least once every hour during the daytime, n(%) 19 (48.72) 60 (35.00) 2.628 0.105
  Drink over 100 mL water every time, n(%) 28 (71.80) 162 (81.19) 1.697 0.193
  Drink water at night, n(%) 13 (33.33) 93 (46.50) 2.292 0.130
  Drink over 200 mL tea every day, n(%) 21 (53.85) 75 (37.50) 3.628 0.057
Tumor located in renal pelvic,n 127 112
  Time of drinking
    When thirsty, n(%) 63 (49.61) 43 (38.40) 3.032 0.082
    Drinking water intentionally, n(%) 64 (50.39) 69 (61.60)
  Drink over 200 mL tea every day, n(%) 35 (35.43) 51 (45.54) 2.527 0.112
  Paying attention to daily water intakes, n(%) 85 (66.93) 55 (49.11) 7.791 0.005#
  Family history of cancer, n(%) 48 (37.80) 25 (22.32) 6.717 0.010*
Tumor located in ureter,n 132 107
  Time of drinking
    When thirsty, n(%) 49 (31.12) 57 (53.27) 6.245 0.012*
    Drinking water intentionally, n(%) 83 (62.88) 50 (46.73)
  Drink at least once every hour during the daytime, n(%) 55 (41.67) 34 (31.78) 2.474 0.116
  Drink water at night, n(%) 51 (38.64) 55 (51.40) 3.902 0.048*
  Drink over 200 mL tea every day, n(%) 64 (48.48) 32 (29.91) 8.487 0.004*
  Paying attention to daily water intakes, n(%) 66 (50.00) 74 (69.16) 8.940 0.003#
  Family history of cancer, n(%) 34 (25.76) 39 (36.45) 3.184 0.074

Table 3

Statistical result of Logistic regression model"

B OR(95%CI) P
Tumor G3
  Drink at least once every hour during the daytime
    No 1.00
    Yes 0.663 1.941 (0.352-1.029) < 0.001#
Multifocal tumor
  Drink at least once every hour during the daytime
    No 1.00
    Yes -1.067 0.344 (1.181-5.582) 0.004#
  Drink over 100 mL water every time
    No 1.00
    Yes -0.876 0.477 (0.225-1.012) 0.046*
Tumor located in renal pelvic
  Paying attention to daily water intakes
    No 1.00
    Yes 0.928 2.530 (1.434-4.463) 0.001#
Tumor located in ureter
  Paying attention to daily water intakes
    No 1.00
    Yes -1.159 0.314 (0.172-0.573) < 0.001#
  Drink over 200mL tea every day
    No 1.00
    Yes -0.572 0.565 (1.200-3.878) 0.208
1 Siegel RL , Miller KD , Jemal A , et al. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69 (1): 7- 34.
doi: 10.3322/caac.21551
2 Audenet F , Isharwal S , Cha EK , et al. Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma[J]. Clin Cancer Res, 2019, 25 (3): 967- 976.
doi: 10.1158/1078-0432.CCR-18-2039
3 Zamboni S , Foerster B , Abufaraj M , et al. Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy[J]. BJU Int, 2019, 124 (5): 738- 745.
doi: 10.1111/bju.14751
4 Belhadj Y , Grande P , Seisen T , et al. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothe-lial carcinoma and its influence on oncological outcomes[J]. BJU Int, 2019, 123 (4): 618- 623.
doi: 10.1111/bju.14647
5 Scott AM , Clark J , Mar CD , et al. Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis[J]. Br J Gen Pract, 2020, 70 (692): e200- e207.
doi: 10.3399/bjgp20X708125
6 卢海梅. 饮食饮水习惯女性泌尿系结石复发的前瞻性研究[J]. 实用临床护理学电子杂志, 2020, 5 (15): 94.
7 Bai Y , Yuan H , Li J , et al. Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence[J]. World J Surg Oncol, 2014, 12, 223.
doi: 10.1186/1477-7819-12-223
8 Hong X , Xu Q , Lan K , et al. The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational atudy[J]. Nutr Cancer, 2018, 70 (8): 1217- 1227.
doi: 10.1080/01635581.2018.1512636
9 李金蓉, 蒙有轩, 廖君娟, 等. 泌尿系结石复发病人饮水习惯调查[J]. 护理研究, 2017, 31 (36): 4691- 4693.
doi: 10.3969/j.issn.1009-6493.2017.36.030
10 Collà Ruvolo C , Nocera L , Stolzenbach LF , et al. Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma[J]. Eur Urol Oncol, 2021, 4 (5): 792- 801.
doi: 10.1016/j.euo.2020.11.005
11 周利群, 熊耕砚, 李学松. 中国人群上尿路尿路上皮癌诊疗策略选择和东西方差异[J]. 临床泌尿外科杂志, 2019, 34 (2): 83- 87.
12 方冬, 黄吉炜, 鲍一歌, 等. 中国上尿路尿路上皮癌人群特征和地区差异: 基于CUDA-UTUC协作组的多中心研究[J]. 中华泌尿外科杂志, 2017, 38 (12): 885- 890.
doi: 10.3760/cma.j.issn.1000-6702.2017.12.002
13 张宁, 崔剑锋, 李岩, 等. 上尿路尿路上皮癌预后生物标志物的研究进展[J]. 临床泌尿外科杂志, 2019, 34 (2): 119- 123.
14 Rolim I , Henriques V , Rolim N , et al. Clinicopathologic analysis of upper urinary tract carcinoma with variant histology[J]. Virchows Arch, 2020, 477 (1): 111- 120.
doi: 10.1007/s00428-020-02745-4
15 陈晗, 王明, 任轲, 刘苑, 等. 不同分期上尿路尿路上皮癌患者预后分析[J]. 临床泌尿外科杂志, 2021, 36 (5): 357- 361.
16 陈金虎, 方卫华, 梁朝朝. 上尿路尿路上皮癌临床治疗进展[J]. 临床泌尿外科杂志, 2021, 36 (5): 415- 420.
17 Martin C , Leiser CL , O'Neil B , et al. Familial cancer clustering in urothelial cancer: a population-based case-control study[J]. J Natl Cancer Inst, 2018, 110 (5): 527- 533.
doi: 10.1093/jnci/djx237
18 曹振朋, 关豹, 方冬, 等. 年轻上尿路尿路上皮癌患者的临床病理和预后特征[J]. 现代泌尿外科杂志, 2017, 22 (9): 661- 665.
doi: 10.3969/j.issn.1009-8291.2017.09.004
19 Han J , Xian Z , Zhang Y , et al. Systematic overview of aristo-lochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms[J]. Front Pharmacol, 2019, 10, 648.
doi: 10.3389/fphar.2019.00648
20 Simon D , Yen S , Cole P . Coffee-drinking and cancer of the lower urinary tract[J]. J Natl Cancer Inst, 1975, 54 (3): 587- 591.
21 Morgan RW , Jain MG . Bladder cancer: smoking, beverages and artificial sweeteners[J]. Can Med Assoc J, 1974, 111 (10): 1067- 1070.
22 Jensen OM , Wahrendorf J , Knudsen JB , et al. The Copenhagen case-control study of bladder cancer. Ⅱ. Effect of coffee and other beverages[J]. Int J Can-cer, 1986, 37 (5): 651- 657.
doi: 10.1002/ijc.2910370503
23 Silverman DT , Alguacil J , Rothman N , et al. Does increased urination frequency protect against bladder cancer?[J]. Int J Can-cer, 2008, 123 (7): 1644- 1648.
doi: 10.1002/ijc.23572
24 Zhou J , Smith S , Giovannucci E , et al. Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort[J]. Am J Epidemiol, 2012, 175 (7): 696- 705.
25 van Hensbergen M , van Osch FHM , Jochems S , et al. Fluid intake and clinicopathological characteristics of bladder cancer: the west midlands bladder cancer prognosis programme[J]. Eur J Cancer Prev, 2020, 29 (2): 110- 118.
26 Wang J , Wu X , Kamat A , et al. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk[J]. Br J Cancer, 2013, 108 (11): 2372- 2380.
27 Jochems SHJ , van Osch FHM , Reulen RC , et al. Total fluid intake and the risk of recurrence in patients with muscle invasive bladder cancer: a prospective cohort study[J]. Bladder Cancer, 2018, 4 (3): 303- 310.
28 Sfakianos JP , Gul Z , Shariat SF , et al. Genetic differences between bladder and upper urinary tract carcinoma: implications for therapy[J]. Eur Urol Oncol, 2021, 4 (2): 170- 179.
[1] Yu-xing GUO,Jian-yun ZHANG,Dian-can WANG,Chuan-bin GUO. Analysis of pathological characteristics of medication-related osteonecrosis of the jaw and discussion of clinical treatment strategies based on the pathological analysis results [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1190-1195.
[2] Xiang DAI,Fei WANG,Yi-qing DU,Yu-xuan SONG,Tao XU. Correlation between adipokine and clinicopathological features and prognosis in upper tract urothelial carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 605-614.
[3] DING Ting-ting,ZENG Chu-xiong,HU Li-na,YU Ming-hua. Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 203-208.
[4] WANG Ying-chun,HUANG Yong-hui,CHANG Hong,YAO Wei,YAN Xiu-e,LI Ke,ZHANG Yao-peng,ZHENG Wei. Characteristics of benign and malignant lesions of ampullary polyps and the accuracy of forceps biopsy [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 204-209.
[5] Bao GUAN,Mai WENG,Hang FAN,Ding PENG,Dong FANG,Geng-yan XIONG,Xue-song LI,Li-qun ZHOU. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy: A single-center retrospective study of 686 patients [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1056-1061.
[6] Run-zhuo MA,Hai-zhui XIA,Min LU,Zhi-ying ZHANG,Qi-ming ZHANG,Jian LU,Guo-liang WANG,Lu-lin MA. Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 665-672.
[7] Xiao-peng ZHANG,Zi-xiong HUANG,Lu-ping YU,Xiao-wei ZHANG,Qing LI,Shi-jun LIU,Tao XU. Clinical and pathological analysis of small renal cell carcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 623-627.
[8] GUAN Bao, CAO Zhen-peng, PENG Ding, LI Yi-fan, ZHAN Yong-hao, LIU Li-bo, HE Shi-ming, XIONG Geng-yan, LI Xue-song, ZHOU Li-qun. Prognostic factors of patients with T2N0M0 upper tract urothelial carcinoma: a single-center retrospective study of 235 patients [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 603-607.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2002, 34(1): 64 -67 .
[2] . [J]. Journal of Peking University(Health Sciences), 2001, 33(5): 457 -461 .
[3] . [J]. Journal of Peking University(Health Sciences), 2008, 40(4): 369 -373 .
[4] . [J]. Journal of Peking University(Health Sciences), 2010, 42(2): 126 -130 .
[5] . [J]. Journal of Peking University(Health Sciences), 2003, 35(5): 499 -502 .
[6] . [J]. Journal of Peking University(Health Sciences), 2001, 33(2): 181 -182 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(6): 663 -665 .
[8] . [J]. Journal of Peking University(Health Sciences), 2008, 40(1): 39 -42 .
[9] . [J]. Journal of Peking University(Health Sciences), 2008, 40(5): 551 -554 .
[10] . [J]. Journal of Peking University(Health Sciences), 2003, 35(3): 307 -310 .